Skip to main content
. 2015 Nov 30;57(1):187–196. doi: 10.3349/ymj.2016.57.1.187

Table 3. Discriminatory Performance of OSTA and the Candidate Models to Identify Men with Osteoporosis and Low BMD.

Sensitivity Specificity PPV NPV NMC NUDT LR (+) LR (-) ROC
% (95% CI) % (95% CI) % (95% CI) % (95% CI) (95% CI) (95% CI) AUC (SE) Statistical difference
Osteoporosis (TFN≤-2.5 or TLS≤-2.5)
 Development dataset
  OSTA (≤0) 86.2 (78.3, 92.1) 49.7 (46.9, 52.6) 13.2 (10.8, 15.9) 97.6 (96.1, 98.7) 138 503 1.72 (1.56, 1.88) 0.28 (0.17, 0.44) 0.680 (0.018)
  OSTA (≤1) 90.8 (83.8, 95.5) 36.9 (34.2, 39.7) 11.3 (9.3, 13.6) 97.8 (96.1, 99.0) 92 632 1.44 (1.34, 1.55) 0.25 (0.14, 0.45) 0.639 (0.016) (ref)
  Model 1 (≤-9) 90.8 (83.8, 95.5) 42.4 (39.6, 45.2) 12.3 (10.1, 14.7) 98.1 (96.6, 99.1) 92 576 1.58 (1.46, 1.70) 0.22 (0.12, 0.39) 0.666 (0.016) <0.001 (ref)
  Model 2 (≤-10) 91.7 (84.9, 96.2) 41.2 (38.4, 44.0) 12.1 (10.0, 14.6) 98.3 (96.7, 99.2) 83 589 1.56 (1.45, 1.68) 0.20 (0.11, 0.38) 0.665 (0.015) 0.004 0.780 (ref)
  Model 3 (≤-12) 90.8 (83.8, 95.5) 43.3 (40.5, 46.1) 12.4 (10.2, 14.9) 98.2 (96.6, 99.1) 92 567 1.60 (1.48, 1.73) 0.21 (0.12, 0.38) 0.671 (0.016) <0.001 0.559 0.311
 Validation dataset
  OSTA (≤0) 84.6 (75.5, 91.3) 48.4 (45.3, 51.5) 12.8 (10.2, 15.7) 97.2 (95.4, 98.5) 154 517 1.64 (1.47, 1.82) 0.32 (0.20, 0.52) 0.665 (0.021) (ref)
  OSTA (≤1) 92.3 (84.8, 96.9) 33.2 (30.3, 36.2) 11.0 (8.9, 13.4) 98.0 (95.9, 99.2) 77 669 1.38 (1.28, 1.49) 0.23 (0.11, 0.48) 0.627 (0.016) (ref)
  Model 1 (≤-9) 87.9 (79.4, 93.8) 39.7 (36.7, 42.8) 11.5 (9.3, 14.1) 97.4 (95.3, 98.7) 121 603 1.46 (1.33, 1.60) 0.30 (0.17, 0.53) 0.638 (0.019) 0.365 (ref)
  Model 2 (≤-10) 85.7 (76.8, 92.2) 37.9 (34.9, 40.9) 11.0 (8.8, 13.5) 96.7 (94.5, 98.3) 143 622 1.38 (1.25, 1.52) 0.38 (0.23, 0.63) 0.618 (0.020) 0.506 0.017 (ref)
  Model 3 (≤-12) 89.0 (80.7, 94.6) 39.5 (36.4, 42.5) 11.6 (9.3, 14.2) 97.6 (95.6, 98.8) 110 606 1.47 (1.35, 1.60) 0.28 (0.15, 0.50) 0.642 (0.018) 0.272 0.703 0.017
Low BMD (TFN≤-2.0 or TLS≤-2.0)
 Development dataset
  OSTA (≤0) 80.0 (74.6, 84.7) 53.1 (50.1, 56.1) 28.6 (25.3, 32.1) 91.9 (89.4, 93.9) 200 470 1.71 (1.56, 1.86) 0.38 (0.29, 0.48) 0.665 (0.015) (ref)
  OSTA (≤1) 88.2 (83.6, 91.9) 40.0 (37.1, 43.0) 25.7 (22.8, 28.7) 93.5 (90.9, 95.6) 118 600 1.47 (1.38, 1.57) 0.29 (0.21, 0.41) 0.642 (0.013) (ref)
  Model 1 (≤-9) 85.5 (80.6, 89.6) 45.6 (42.6, 48.6) 27.0 (24.0, 30.2) 93.1 (90.5, 95.1) 146 544 1.57 (1.46, 1.69) 0.32 (0.23, 0.43) 0.656 (0.013) 0.091 (ref)
  Model 2 (≤-10) 85.5 (80.6, 89.6) 44.2 (41.2, 47.2) 26.5 (23.5, 29.6) 92.8 (90.3, 94.9) 146 559 1.53 (1.42, 1.65) 0.33 (0.24, 0.45) 0.648 (0.013) 0.434 0.142 (ref)
  Model 3 (≤-12) 85.1 (80.1, 89.2) 46.5 (43.5, 49.6) 27.2 (24.2, 30.5) 93.0 (90.5, 95.0) 149 535 1.59 (1.48, 1.71) 0.32 (0.24, 0.43) 0.658 (0.014) 0.071 0.749 0.160
 Validation dataset
  OSTA (≤0) 77.1 (70.1, 82.6) 51.0 (47.7, 54.3) 26.9 (23.4, 30.1) 90.5 (88.0, 92.9) 229 490 1.57 (1.43, 1.74) 0.45 (0.35, 0.58) 0.641 (0.017) (ref)
  OSTA (≤1) 86.7 (81.3, 91.0) 35.2 (32.1, 38.4) 23.8 (20.8, 27.0) 91.9 (88.5, 94.5) 134 648 1.34 (1.25, 1.44) 0.38 (0.27, 0.54) 0.609 (0.014) (ref)
  Model 1 (≤-9) 84.8 (79.2, 89.3) 42.7 (39.4, 46.0) 25.7 (22.4, 29.1) 92.3 (89.3, 94.7) 153 574 1.48 (1.36, 1.60) 0.36 (0.26, 0.50) 0.637 (0.015) 0.004 (ref)
  Model 2 (≤-10) 86.2 (80.8, 90.6) 41.1 (37.9, 44.4) 25.5 (22.3, 28.8) 92.7 (89.7, 95.1) 139 589 1.46 (1.36, 1.58) 0.34 (0.24, 0.48) 0.636 (0.015) 0.009 0.931 (ref)
  Model 3 (≤-12) 86.7 (81.3, 91.0) 42.7 (39.4, 46.0) 26.1 (22.9, 29.5) 93.2 (90.3, 95.4) 134 574 1.50 (1.39, 1.63) 0.32 (0.23, 0.46) 0.647 (0.014) 0.001 0.287 0.218

OSTA, Osteoporosis Self-assessment Tool for Asians; BMD, bone mineral density; PPV, positive predictive value; NPV, negative predictive value; NMC, the number of missed cases which represents the number of undetected osteoporotic subjects (i.e., false negatives) per 1000 subjects; NUDT, the number of unnecessary DXA tests which represents the number of subjects referred for DXA testing (i.e., false positives) per 1000 subjects; ROC, receiver operation characteristics; AUC, area under the curve; SE, standard error; TFN, T-score at femoral neck; TLS, T-score at lumbar spine; DXA, dual-energy X-ray absorptiometry; ALP, alkaline phosphatase.

Model 1 included age and weight, model 2 added regular exercise, and model 3 added low vitamin D and an elevated ALP.